Table 2.
[en] Overall survival as a function of baseline demographic, clinical, and tumor features in all patients with noninvasive disease
| Variable | Category | No. (%) of all patients | No. (%) of patients who died during follow-up | Unadjusted hazard ratio | 95% confidence interval | p value |
|---|---|---|---|---|---|---|
| Total | 390 (100) | 137 (35.1) | ||||
| Gender | Female | 91 (23.3) | 31 (34.1) | [em] | [em] | |
| Male | 299 (76.7) | 106 (35.5) | 1.13 | 0.76[en]1.6 9 |
0.5414 | |
| Race* | White | 325 (83.3) | 116 (35.7) | [em] | [em] | |
| Black | 59 (15.1) | 31 (52.5) | 1.25 | 0.78[en]1.9 9 |
0.3550 | |
| Age | ≤65 | 122 (31.3) | 27 (22.1) | [em] | [em] | |
| 66[en]75 | 128 (32.8) | 39 (30.5) | 1.26 | 0.77[en]2.0 6 |
0.3574 | |
| ≥76 | 140 (35.9) | 71 (50.7) | 2.64 | 1.69[en]4.1 7 |
0.0001 | |
| Stage | 0 | 287 (73.6) | 93 (32.4) | [em] | [em] | |
| I | 103 (26.4) | 44 (42.7) | 1.40 | 0.98[en]2.0 0 |
0.0685 | |
| Comorbidity | 0 | 137 (35.1) | 35 (25.5) | [em] | [em] | |
| 1 | 114 (29.2) | 34 (29.8) | 1.31 | 0.82[en]2.1 0 |
0.2614 | |
| 2 | 89 (22.8) | 40 (44.9) | 2.15 | 1.36[en]3.3 8 |
0.0010 | |
| 3 | 50 (12.8) | 28 (56.0) | 3.57 | 2.17[en]5.8 9 |
0.0001 | |
| Grade** | Low (I,II) | 266 (68.2) | 91 (34.2) | [em] | [em] | |
| High (III,IV) |
87 (22.3) | 34 (39.1) | 1.25 | 0.85[en]1.8 4 |
0.2633 |
*
Six patients were of another ethnicity and were censored owing to small sample size.
**
Thirty-seven patients were not assigned a grade and were censored.